| Basics |
Masimo Corporation Common Stock
Masimo Corp is a medical technology company. The company develops, manufactures, and markets noninvasive monitoring technologies. Its product includes noninvasive blood constituent and brain and breath monitoring.
|
| IPO Date: |
August 8, 2007 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$8.53B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.27 | 1.43%
|
| Avg Daily Range (30 D): |
$2.22 | 1.43%
|
| Avg Daily Range (90 D): |
$3.09 | 1.90%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.43M |
| Avg Daily Volume (30 D): |
.55M |
| Avg Daily Volume (90 D): |
.51M |
| Trade Size |
| Avg Trade Size (Sh.): |
74 |
| Avg Trade Size (Sh.) (30 D): |
40 |
| Avg Trade Size (Sh.) (90 D): |
40 |
| Institutional Trades |
| Total Inst.Trades: |
8,399 |
| Avg Inst. Trade: |
$4.9M |
| Avg Inst. Trade (30 D): |
$6.21M |
| Avg Inst. Trade (90 D): |
$8.25M |
| Avg Inst. Trade Volume: |
.05M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$7.44M |
| Avg Closing Trade (30 D): |
$9.92M |
| Avg Closing Trade (90 D): |
$12.21M |
| Avg Closing Volume: |
61.31K |
|
|
|
|
| Financials |
| |
TTM |
Q4 2025 |
Q4 2024 |
|
Basic EPS
|
$-9.25
|
$-3.17
|
$-6.56
|
|
Diluted EPS
|
$-9.19
|
$-3.12
|
$-6.54
|
|
Revenue
|
$ 1.97B
|
$ 372M
|
$ 600.7M
|
|
Gross Profit
|
$ 996.7M
|
$ 234M
|
$ 244.7M
|
|
Net Income / Loss
|
$ -494.5M
|
$ -170.7M
|
$ -349.6M
|
|
Operating Income / Loss
|
$ -222.7M
|
$ 78M
|
$ -359.1M
|
|
Cost of Revenue
|
$ 976.9M
|
$ 138M
|
$ 356M
|
|
Net Cash Flow
|
$ 12.5M
|
$ -4.9M
|
$ 17.7M
|
|
PE Ratio
|
|
|
|
|
